Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 12—December 2006
Research

Evaluating Detection of an Inhalational Anthrax Outbreak

David L. Buckeridge*Comments to Author , Douglas K. Owens†‡, Paul Switzer‡, John Frank§, and Mark A. Musen‡
Author affiliations: *McGill University, Montreal, Quebec, Canada; †Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA; ‡Stanford University, Stanford, California, USA; §University of Toronto, Toronto, Ontario, Canada

Main Article

Figure 2

Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Figure 2. Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Main Article

Page created: October 04, 2011
Page updated: October 04, 2011
Page reviewed: October 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external